These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19839288)

  • 1. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia.
    Buxton JA; Rothon D; Durigon M; Lem M; Tu AW; Remple VP; Cook D; Krajden M
    Can J Public Health; 2009; 100(2):121-4. PubMed ID: 19839288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities.
    Mehrabadi A; Craib KJ; Patterson K; Adam W; Moniruzzaman A; Ward-Burkitt B; Schechter MT; Spittal PM;
    Int J Drug Policy; 2008 Apr; 19(2):159-68. PubMed ID: 17870461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV co-infection in HIV positive population in British Columbia, Canada.
    Buxton JA; Yu A; Kim PH; Spinelli JJ; Kuo M; Alvarez M; Gilbert M; Krajden M
    BMC Public Health; 2010 Apr; 10():225. PubMed ID: 20429917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex trade involvement and rates of human immunodeficiency virus positivity among young gay and bisexual men.
    Weber AE; Craib KJ; Chan K; Martindale S; Miller ML; Schechter MT; Hogg RS
    Int J Epidemiol; 2001 Dec; 30(6):1449-54; discussion 1455-6. PubMed ID: 11821362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain.
    Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Brugal MT;
    Gac Sanit; 2013; 27(4):338-43. PubMed ID: 23578527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.
    Miller CL; Wood E; Spittal PM; Li K; Frankish JC; Braitstein P; Montaner JS; Schechter MT
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):743-9. PubMed ID: 15167294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).
    Frederick T; Burian P; Terrault N; Cohen M; Augenbraun M; Young M; Seaberg E; Justman J; Levine AM; Mack WJ; Kovacs A
    AIDS Patient Care STDS; 2009 Nov; 23(11):915-23. PubMed ID: 19877800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior associated with HIV and HCV infection in female prison inmates in São Paulo, Brazil].
    Strazza L; Massad E; Azevedo RS; Carvalho HB
    Cad Saude Publica; 2007 Jan; 23(1):197-205. PubMed ID: 17187118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and correlates of HIV and HCV among injecting drug users in Edmonton, Alberta.
    Plitt SS; Gratrix J; Hewitt S; Conroy P; Parnell T; Lucki B; Pilling V; Anderson B; Choudri Y; Archibald CP; Singh AE
    Can J Public Health; 2010; 101(1):50-5. PubMed ID: 20364539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran.
    Khademi N; Skakiba E; Khodadoust M; Khoramdad M
    Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture.
    Larrat S; Bourdon C; Baccard M; Garnaud C; Mathieu S; Quesada JL; Signori-Schmuck A; Germi R; Blanc M; Leclercq P; Hilleret MN; Leroy V; Zarski JP; Morand P
    J Clin Virol; 2012 Nov; 55(3):220-5. PubMed ID: 22901327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
    Bodsworth NJ; Cunningham P; Kaldor J; Donovan B
    Genitourin Med; 1996 Apr; 72(2):118-22. PubMed ID: 8698359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
    Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
    Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
    Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
    Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities.
    Calzavara L; Ramuscak N; Burchell AN; Swantee C; Myers T; Ford P; Fearon M; Raymond S
    CMAJ; 2007 Jul; 177(3):257-61. PubMed ID: 17664449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.